The Archdiocese of Atlanta supports SB 456, a state bill relating to restrictions on chemical abortions. Let’s pray that the bill gets out of committee with no amendments added. More than half of abortions now are chemical (Click Here to Read an Article from National Review).
More From The Georgia Life Alliance:
The Biden Administration’s FDA has ended an Obama-era safety rule that would now allow abortion pills to be provided via telemedicine or sent directly through the mail without a doctor ever examining the woman in person.
“Georgia has a maternal mortality crisis, and women dying from complications such as obstetric hemorrhaging – the chief side effect of the abortion pill,” said GLA’s Joshua Edmonds. “This rule change from the FDA will only worsen the crisis and undermine the efforts of the Georgia Maternal Mortality Review Committee and the DPH over the last several years to protect our communities.”
A recent, first-of-its-kind study found that the abortion pill is a major public health threat. The study analyzed 423,000 confirmed abortions and found that the rate of abortion-related emergency room visits following the abortion pill increased by more than 500% from 2002 through 2015 (Studnicki, et al., Health Services Research and Managerial Epidemiology, January 2021).
The Women’s Health & Safety Act will require a pregnant woman to receive an in-person exam from a licensed physician prior to an abortion to ensure that she is not at increased risk of complications as well as prohibit abortion pills from being provided via telemedicine or sent through the mail. Similar legislation has been passed in OK, TX, IN, AZ, MT, and SD.
Joey Martineck, M.T.S.
Director of Respect Life Ministry
Office of Life, Dignity and Justice
2401 Lake Park Dr. SE • Smyrna, GA • 30080 • f: 404.920.7361 • o: 404.920.7362
firstname.lastname@example.org • archatl.com
Confidentiality Notice: This message contains confidential information and is intended only for the individual named. This communication may contain information that is proprietary, privileged or confidential. If you are not the named addressee, you are not authorized to read, print, retain, copy or disseminate this message or any part of it. If you have received this message in error, please notify the sender immediately by e-mail and delete all copies of the message.